In this study, authors have shown how the survival of patients with large B cell lymphoma has notably improved in recent years since introducing new therapies, such as CAR-T cell therapy 👉bit.ly/3vTkBPK

🚨New publication alert 🚨

👉bit.ly/3J3TFQ3

Are you curious to know if Sex matching is important in generating successful Xenotransplantation? Have a look at our latest paper for the answer! #AML #HSCs #Haematopoiesis #ImmunodeficientMice #EHA HemaSphere Journal (IF = 9.1) The Crick
onlinelibrary.wiley.com/doi/full/10.10…
#

Published in HemaSphere Journal (IF = 9.1) today! Treatment outcomes in patients with large B‐cell lymphoma after progression to #CART

Great Spain+UK joint effort, big thanks to Andrea Kuhnl Pau Abrisqueta Josu Iraola Truchuelo Victor Navarro and all participating colleagues!

onlinelibrary.wiley.com/doi/full/10.10…

Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP-ALL of all age classes 

Read more about this, always #openaccess 👉bit.ly/44j8NmA

In my view this paper should become a landmark reference for all late phase clinical trials in #MDSsm in terms of protocol development, #PRO logistics, data collection, analysis & reporting International Consortium for MDS (icMDS) HemaSphere Journal (IF = 9.1)

New in our April issue:

Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma
 
Read about it here👉bit.ly/4ahTUD1

A list of journals every young hematologist should read🩸:
NEJM
The Lancet The LancetHaem
Journal of Clinical Oncology
Blood Journal
JAMA Oncology JAMA Network Open
AmericanJournalofHematology
HemaSphere Journal (IF = 9.1)
Blood Cancer Journal Leukemia Journal
Blood Cancer Discovery Clinical Cancer Research
Haematologica
JTH British Journal of Haematology

The #EHA2024 abstracts are now online and ready for your browsing. HemaSphere will be formally publishing the abstract book in time for the start of congress. Congrats to all accepted abstract authors, and happy reading to all. 🥳

No submission fee, no printing fee. Kudos to European Hematology Association 🙌🏼

Thank you for the free poster printing service on site. Saves us 💰 and the trouble of carrying posters on the flight ✈️

This is pharma 💰 well spent 🙌🏼

#MedTwitter

HemaSphere Chief Editor Prof Jan Cools selects Editor Highlights, calling out must-read papers. This month's pick: Circulating tumor plasma cells & peripheral blood measurable residual disease assessment in MM patients not planned for upfront transplant 👉bit.ly/4ahO3xE

The more we share, the more we learn 🤝.
#HemaSphere publications are free to view, download, and share. No subscription. No pay wall. Have a browse - we welcome your engagement!

💻: bit.ly/4bpbV3k

#openaccess #hematology #research #guidelines

Instantly hear when new #HemaSphere publications are online. E-alerts are free & it takes 1 minute to enroll. Plus, you can customize email frequency! 👉 hsphere.pub/read.

We are proud to be the open access research journal of European Hematology Association, published by Wiley Oncology & Hematology.

HemaTopics are HemaSphere pubs focusing on🔥heme topics including recent research developments, updates on diagnosis and treatment, policy and guidelines news, and more. This week we focus on the latest HemaTopic by Sci Ed C de Bock  👉bit.ly/43KMqWP

Divergences within medical communities foster innovation but also present challenges across different settings. New online: the EHA board examines the WHO 2017 blue book vs later 2022 updates. Read about the significant classification differences, expertly detailed in 2 included

In this paper, authors assess the association between CHIP and COVID-19 severity in the Danish population using univariable and multivariable logistic regressions👉bit.ly/3v5rs89

Read this retrospective evaluation of ivosidenib in R/R AML after hematopoietic cell transplantation in the March issue of HemaSphere.

👉bit.ly/3v7BNAu

#AML #HemaSphere

HemaSphere's April issue is now online. Please enjoy reading and sharing (all #OpenAccess ) with your networks
👉bit.ly/3JCPMll
European Hematology Association
  #hematology